Ranked #1
Diagnosis and management of non-adherence in hypertension treatment - report from ESH2022
Diagnosis and management of non-adherence in hypertension treatment - report from ESH2022
Professor Jan Václavík held a lecture at the recent European Society of Hypertension 2022 Congress about the diagnosis o... Read more
14 Jul 2022
•
9mins
Ranked #2
Implementation of the 2019 lipid guidelines: where are we now? - report from EAS2022
Implementation of the 2019 lipid guidelines: where are we now? - report from EAS2022
Professor Alberico L. Catapano spoke about the European Atherosclerosis Society annual meeting, the novelties presented ... Read more
14 Jul 2022
•
16mins
Ranked #3
Nocturnal hypertension - report from ESH2022
Nocturnal hypertension - report from ESH2022
At the recent European Society of Hypertension 2022 annual congress, nocturnal hypertension addressed as one of the six ... Read more
12 Jul 2022
•
7mins
Ranked #4
Blood pressure management in older frail patients - report from ESH2022
Blood pressure management in older frail patients - report from ESH2022
There are long standing debates around the blood pressure lowering treatment in elderly patients. Fortunately more and ... Read more
11 Jul 2022
•
12mins
Ranked #5
Lifelong burden of hypertension - report from ESH2022
Lifelong burden of hypertension - report from ESH2022
Professor Giuseppe Mancia spoke about a very interesting session from the recent European Society of Hypertension congre... Read more
8 Jul 2022
•
11mins
Ranked #6
New pathogenic insights in chronic urticaria - report from EADV Symposium 2022
New pathogenic insights in chronic urticaria - report from EADV Symposium 2022
Professor Ana Giménez-Arnau chaired a very interesting session about chronic urticaria and the new pathogenic insights a... Read more
6 Jul 2022
•
7mins
Ranked #7
Novelties in the diagnosis and management of primary aldosteronism - report from ESH2022
Novelties in the diagnosis and management of primary aldosteronism - report from ESH2022
Professor Constantine Stratakis co-chaired a meet the expert session at the 31st European Meeting on Hypertension and C... Read more
21 Jun 2022
•
9mins
Ranked #8
Results from the phase 3 PARADIGM trial - report from ASCO2022
Results from the phase 3 PARADIGM trial - report from ASCO2022
Professor Takayuki Yoshino presented at the recent ASCO 2022 new data about the PARADIGM trial. He summerized us the mai... Read more
16 Jun 2022
•
5mins
Ranked #9
Detecting elevated lipoprotein(a) and addressing the ASCVD risks - report from EAS2022
Detecting elevated lipoprotein(a) and addressing the ASCVD risks - report from EAS2022
Professor Florian Kronenberg presented the lipoprotein(a) consensus panel recommendations in the recent European Atheros... Read more
16 Jun 2022
•
7mins
Ranked #10
Who needs injectable therapies for cholesterol lowering or statins and ezetimibe are enough for CVD prevention? - report from EAS2022
Who needs injectable therapies for cholesterol lowering or statins and ezetimibe are enough for CVD prevention? - report from EAS2022
Professor Carl Orringer was a co-chair of a recent symposium at the European Atherosclerosis Society 2022 session in Mil... Read more
15 Jun 2022
•
6mins